The DOI matches its Crossref record; 71 of the 71 references it cites were found in a registry or an index.
The infarcted myocardium Simply dead tissue, or a lively target for therapeutic interventions
Open accessAbstract
Time for primary review 32 days. It has been known for many years that infarction of the heart induces prominent alterations of cardiac structure. The most apparent is the scarring of the infarct. Structural changes after infarction are, however, not limited to the infarcted area, but also extend into the non-infarcted myocardium. Changes in the non-infarcted myocardium include hypertrophy of the cardiomyocytes, growth of the capillary network, and an increase in interstitial collagen. Cardiac structure is a major determinant of function, which is depressed after myocardial infarction (MI). After infarction, both short term and long term compensatory or regulatory mechanisms are activated. Often these mechanisms also affect cardiac structure. Although activation of these compensatory mechanisms may be beneficial early after infarction, they may have adverse effects, when activation is continued for a longer time. Indeed, pharmacological treatments that block the long term activation of these compensatory mechanisms, like angiotensin converting enzyme inhibitors (ACEI) that block the renin—angiotensin system (RAS), have been shown to improve cardiac function after infarction. Although we know that cardiac function and structure are closely related and do indeed both change after infarction, it is largely unknown what the exact structural component is that causes the reduction in cardiac function after infarction. Also it is not clear which structural component should be targeted for effective pharmacotherapy after infarction. In this review we attempt to clarify the structural alterations after infarction. We and others have focused for many years on the potential importance of changes in the vital non-infarcted myocardium and, indeed, found several alterations in cardiac structure after infarction and effects thereon of drugs that improved cardiac function. However, recent data in animal studies and humans point to the importance of the infarct itself as a potential target for intervention. The infarct appears to be more than just dead tissue and infarct healing turns out to be an active and well controlled process. Also, interventions in infarct healing appear to affect cardiac function. Therefore we hypothesize that changes in the structure of the infarct may be of major importance for the maintenance of cardiac function. Future pharmacological interventions should, for this reason, not only be directed to the non-infarcted myocardium, but also to the mechanisms that control adequate infarct healing. After describing the components of the normal heart, we will focus on the characteristics of cardiac wound healing and some of the control mechanisms involved, with special emphasis on the control of architectural adaptations in the infarct. Also changes in the non-infarcted myocardium will be described. Subsequently we will focus on the effects of interventions on both the infarcted and non-infarcted myocardium and the regulation of granulation tissue formation. The vast majority of the volume of the normal adult mammalian heart is taken up by cardiomyocytes. Cardiomyocytes are regarded to be terminally differentiated cells, and constitute the core of the contractile unit of the heart. Cardiomyocytes contain several specific contractile proteins and contract in a rhythmic and coordinated fashion. They are surrounded by capillaries, that are lined by endothelial cells, and provide oxygen to the cardiomyocytes. Capillaries surround myocytes in a hexagonal fashion which limits the diffusion distance of oxygen. The structural backbone of the heart is provided by the extracellular matrix. Extracellular matrix proteins, like type IV collagen, are present in the basement membrane surrounding the cardiomyocyte. Other collagen types, like type I, III and VI collagen, are present in and around the coronary arteries and in the interstitium. In a normal adult heart interstitial collagens make up 1–2% of the volume of the heart. Extracellular matrix proteins are produced in (myo-)fibroblasts, which are also found in the interstitium. Together with the endothelial cells they make up the majority of the cell number in the heart. Cardiomyocytes, extracellular matrix and cardiac vasculature are major determinants of cardiac function. Moreover, remodeling of the heart may constitute one of the most important and powerful long-term adaptive mechanisms to changes in load. Unloading of the heart causes rapid regression of cardiac mass, through myocyte atrophy. Similarly, cardiomyocytes respond within 1 h to an increased load by increasing protein synthesis. The outcome of the latter hypertrophic response depends upon the nature of the imposed load, and may constitute concentric hypertrophy (in which the ratio of wall thickness and diameter of the left ventricular cavity increases) or eccentric hypertrophy (in which wall thickness: cavity diameter decreases). Cardiac hypertrophy has also been distinguished as physiologic or patho
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Pfeffer, M. A., & Braunwald, E. (1990) · Circulation · doi:10.1161/01.cir.81.4.1161 · Cited by 2,877
A Calcineurin-Dependent Transcriptional Pathway for Cardiac Hypertrophy
Molkentin, J. D., Lu, J.-R., Antos, C. L., Markham, B., Richardson, J., Robbins, J., Grant, S. R., & Olson, E. N. (1998) · Cell · doi:10.1016/s0092-8674(00)81573-1 · Cited by 2,566
Weber, K. T., & Brilla, C. G. (1991) · Circulation · doi:10.1161/01.cir.83.6.1849 · Cited by 2,027
Apoptosis in the Failing Human Heart
Olivetti, G., Abbi, R., Quaini, F., Kajstura, J., Cheng, W., Nitahara, J. A., Quaini, E., Di Loreto, C., Beltrami, C. A., Krajewski, S., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199704173361603 · Cited by 1,673
Sadoshima, J.-I., Xu, Y., Slayter, H. S., & Izumo, S. (1993) · Cell · doi:10.1016/0092-8674(93)90541-w · Cited by 1,348
Desmoulière, A., Redard, M., Darby, I. A., & Gabbiani, G. (1995) · Europe PMC (PubMed Central) · Cited by 1,189
Effect of Captopril on Progressive Ventricular Dilatation after Anterior Myocardial Infarction
Pfeffer, M. A., Lamas, G. A., Vaughan, D. E., Parisi, A. F., & Braunwald, E. (1988) · New England Journal of Medicine · doi:10.1056/nejm198807143190204 · Cited by 1,103
Kajstura, J., Cheng, W. N., Krzysztof Reiss, F., CLARK, W. A., Sonnenblick, E. H., Krajewski, S., Reed, J., Olivetti, G., & Anversa, P. (1996) · PubMed · Cited by 1,039
Stoll, M., Steckelings, U. M., Paul, M., Bottari, S. P., Metzger, R., & Unger, T. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117710 · Cited by 906
Influence of chronic captopril therapy on the infarcted left ventricle of the rat.
Pfeffer, J. M., Pfeffer, M. A., & Braunwald, E. (1985) · Circulation Research · doi:10.1161/01.res.57.1.84 · Cited by 808
Cited by
Nahrendorf, M., Swirski, F. K., Aikawa, E., Stangenberg, L., Wurdinger, T., Figueiredo, J.-L., Libby, P., Weissleder, R., & Pittet, M. J. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20070885 · Cited by 2,300
The inflammatory response in myocardial infarction
Frangogiannis, N. (2002) · Cardiovascular Research · doi:10.1016/s0008-6363(01)00434-5 · Cited by 2,011
Monocytes: Protagonists of Infarct Inflammation and Repair After Myocardial Infarction
Nahrendorf, M., Pittet, M. J., & Swirski, F. K. (2010) · Circulation · doi:10.1161/circulationaha.109.916346 · Cited by 799
Myocardial remodeling after infarction: the role of myofibroblasts
van den Borne, S. W. M., Diez, J., Blankesteijn, W. M., Verjans, J., Hofstra, L., & Narula, J. (2010) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2009.199 · Cited by 739
Infarct scar: a dynamic tissue
Sun, Y. (2000) · Cardiovascular Research · doi:10.1016/s0008-6363(00)00032-8 · Cited by 510
Metadata
- Authors
- Cleutjens, J.
- Venue
- Cardiovascular Research
- Publisher
- Oxford University Press (OUP)
- Published
- 1999-11
- Volume
- 44
- Issue
- 2
- Pages
- 232-241
- ISSN
- 0008-6363 (ISSN-L)
- OpenAlex
- W2178596412
- Cited by
- 268
- References
- 71
- FWCI
- 2.94
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The infarcted myocardium Simply dead tissue, or a lively target for therapeutic interventions. https://app.cochat.ai/papers/10.1016/s0008-6363(99)00212-6
- The paper
- Cleutjens, J. (1999). The infarcted myocardium Simply dead tissue, or a lively target for therapeutic interventions. Cardiovascular Research. https://doi.org/10.1016/s0008-6363(99)00212-6
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.